在稳定的COPD患者的外周肺部中,SERPIN-蛋白酶平衡受损
Antonino Di Stefano1, Francesco Nucera2, Umberto Rosani3
1Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Istituti Linici Scientifici Maugeri, IRCCS, Respiratory Rehabilitation Unit of Gattico-Veruno, 28013 Novara, Italy.
International journal of molecular sciences
|April 17, 2025
概括
慢性肺炎肺部显示蛋白酶和SERPIN (抗蛋白酶) 的不平衡,组织等离子素激活剂和caspase-1的水平发生变化. 这些变化可能会导致慢性阻塞性肺病患者的肺损伤.
科学领域:
- 肺部医学 肺部医学
- 生物化学 生物化学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 蛋白酶-抗蛋白酶平衡对于诸如炎症和组织重塑等生物过程至关重要.
- 这个系统的不平衡与各种疾病有关,包括慢性阻塞性肺病 (COPD).
研究的目的:
- 为了研究稳定的COPD患者肺膜内SERPINs (抗蛋白酶) 和相关蛋白酶之间的平衡.
- 为了确定有助于COPD肺损伤的特定分子变化.
主要方法:
- 横截面研究分析了轻度中度COPD患者,控制吸烟者和非吸烟者的肺组织.
- 使用了转录组分析,免疫组织化学 (IHC) 和ELISA测试.
- 测量了人类SERPIN和蛋白酶的表达和定位.
主要成果:
- 转录组数据显示,COPD患者的组织等离子素激活剂 (tPA),甲素-L,酶-1和几种SERPIN的mRNA增加.
- 在COPD和吸烟者组中,IHC显示tPA,cathepsin-L,SERPINB5和SERPINB13蛋白质的升高.
- 在COPD和吸烟者中,SERPINA6水平下降,与肺功能相关,而caspase-1水平升高.
结论:
- 在吸烟者和稳定的COPD患者的肺部蛋白质水平上观察到SERPIN和蛋白酶的显著失衡.
- 蛋白酶-抗蛋白酶平衡中的这些分子变化可能会导致容易患上COPD的个体肺膜损伤.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Pathogenesis and Clinical Features
174
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
174
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
123
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
123


